Published in Urology on February 01, 2007
Urinary biomarkers for the early diagnosis of kidney cancer. Mayo Clin Proc (2010) 1.24
Metabolic profiling reveals key metabolic features of renal cell carcinoma. J Cell Mol Med (2011) 1.23
Brain-type and liver-type fatty acid-binding proteins: new tumor markers for renal cancer? BMC Cancer (2009) 0.90
Obesity and cancer progression: is there a role of fatty acid metabolism? Biomed Res Int (2015) 0.84
Molecular diagnostic trends in urological cancer: biomarkers for non-invasive diagnosis. Curr Med Chem (2012) 0.83
Analysis of the regulation of fatty acid binding protein 7 expression in human renal carcinoma cell lines. BMC Mol Biol (2011) 0.81
Elevated expression of FABP3 and FABP4 cooperatively correlates with poor prognosis in non-small cell lung cancer (NSCLC). Oncotarget (2016) 0.77
Candidates for tumor markers of cervical cancer discovered by proteomic analysis. J Korean Med Sci (2012) 0.76
Metabolism-related enzyme alterations identified by proteomic analysis in human renal cell carcinoma. Onco Targets Ther (2016) 0.75
Functional analysis of fatty acid binding protein 7 and its effect on fatty acid of renal cell carcinoma cell lines. BMC Cancer (2017) 0.75
The increased expression of fatty acid-binding protein 9 in prostate cancer and its prognostic significance. Oncotarget (2016) 0.75
Expression and functional role of β3 -adrenoceptors in the human ureter. Int J Urol (2013) 2.13
Laparoscopic simultaneous bilateral adrenalectomy for testosterone-secreting bilateral adrenal tumors. Int J Urol (2013) 2.03
Prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era: a cooperative group report of 1463 patients. Eur Urol (2009) 2.03
Collecting duct (Bellini duct) renal cell carcinoma: a nationwide survey in Japan. J Urol (2006) 1.78
Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4. Am J Surg Pathol (2009) 1.63
Randomized, double-blind, placebo- and propiverine-controlled trial of the once-daily antimuscarinic agent solifenacin in Japanese patients with overactive bladder. BJU Int (2007) 1.61
Maintenance intravesical bacillus Calmette-Guérin instillation for Ta, T1 cancer and carcinoma in situ of the bladder: randomized controlled trial by the BCG Tokyo Strain Study Group. Int J Urol (2010) 1.51
Hydroxyproline metabolism in mouse models of primary hyperoxaluria. Am J Physiol Renal Physiol (2011) 1.49
Effects of calcineurin inhibitors on pharmacokinetics of mycophenolic acid and its glucuronide metabolite during the maintenance period following renal transplantation. Biol Pharm Bull (2006) 1.48
Pharmacological effect of TRK-380, a novel selective human β3-adrenoceptor agonist, on mammalian detrusor strips. Urology (2011) 1.47
Aggressive angiomyxoma in the scrotum expressing androgen and progesterone receptors. Int J Urol (2003) 1.47
Resistive index as risk factor for acute urinary retention in patients with benign prostatic hyperplasia. Urology (2010) 1.46
Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade. J Urol (2008) 1.41
Arteriosclerosis related factors had no clinical significant correlation with resistive index in symptomatic benign prostatic hyperplasia. Urology (2010) 1.39
BK virus nephropathy: clinical experience in a university hospital in Japan. Int J Urol (2009) 1.38
S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast. Curr Cancer Drug Targets (2008) 1.37
Cytoplasmic and/or nuclear accumulation of the beta-catenin protein is a frequent event in human osteosarcoma. Int J Cancer (2002) 1.37
Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway. J Clin Invest (2011) 1.35
Usp46 is a quantitative trait gene regulating mouse immobile behavior in the tail suspension and forced swimming tests. Nat Genet (2009) 1.33
Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-alpha and stromal-derived factor-1 released in stroma. Am J Pathol (2006) 1.31
Key predictive factors of axitinib (AG-013736)-induced proteinuria and efficacy: a phase II study in Japanese patients with cytokine-refractory metastatic renal cell Carcinoma. Eur J Cancer (2011) 1.26
Spontaneous rupture of the urinary bladder presenting as oliguric acute renal failure. Intern Med (2006) 1.26
Potential use of Sox9 gene therapy for intervertebral degenerative disc disease. Spine (Phila Pa 1976) (2003) 1.25
Primitive neuroectodermal tumor of the breast: immunohistochemistry and fluorescence in situ hybridization. Pathol Int (2007) 1.21
Bladder Cancer Working Group report. Jpn J Clin Oncol (2010) 1.21
Measurement of bisphenol A concentrations in human colostrum. Chemosphere (2006) 1.17
Laparoscopic adrenalectomy for large adrenal tumors. J Endourol (2005) 1.16
Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma. Clin Cancer Res (2002) 1.14
Prevalence of renal cell carcinoma: a nation-wide survey in Japan, 2002. Int J Urol (2007) 1.14
Expression and functional role of beta-adrenoceptors in the human urinary bladder urothelium. Naunyn Schmiedebergs Arch Pharmacol (2008) 1.13
Anatomic and molecular pathology of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg (2003) 1.13
Double gallbladder. J Gastroenterol Hepatol (2004) 1.13
Outline of JUA clinical guidelines for benign prostatic hyperplasia. Int J Urol (2011) 1.11
Efficacy and safety of axitinib versus sorafenib in metastatic renal cell carcinoma: subgroup analysis of Japanese patients from the global randomized Phase 3 AXIS trial. Jpn J Clin Oncol (2013) 1.10
Immunohistochemical analysis of the progression of flat and papillary preneoplastic lesions in intrahepatic cholangiocarcinogenesis in hepatolithiasis. Liver Int (2007) 1.10
Seventh Joint Meeting of K-J-CaP and CaPSURE: extending the global initiative to improve prostate cancer management. Prostate Int (2014) 1.08
Detection of the archetypal regulatory region of JC virus from the tonsil tissue of patients with tonsillitis and tonsilar hypertrophy. J Neurovirol (2004) 1.07
Prediction of postoperative renal function by preoperative serum creatinine level and three-dimensional diagnostic image reconstruction in patients with renal cell carcinoma. Urology (2004) 1.02
Clinical guideline for male lower urinary tract symptoms. Int J Urol (2009) 1.02
Peritoneal fixation prevents dislocation of Tenckhoff catheter. Perit Dial Int (2011) 1.02
Expression of matrix metalloproteinase 7 is an unfavorable postoperative prognostic factor in cholangiocarcinoma of the perihilar, hilar, and extrahepatic bile ducts. Hum Pathol (2008) 1.01
Cyclooxygenase-2 is involved in the up-regulation of matrix metalloproteinase-9 in cholangiocarcinoma induced by tumor necrosis factor-alpha. Am J Pathol (2009) 1.00
Late recurrence of renal cell carcinoma: retrospective and collaborative study of the Japanese Society of Renal Cancer. Urology (2010) 0.99
Demonstration of aluminum in amyloid fibers in the cores of senile plaques in the brains of patients with Alzheimer's disease. J Inorg Biochem (2009) 0.99
Evaluation of S100A10, annexin II and B-FABP expression as markers for renal cell carcinoma. Cancer Sci (2007) 0.98
Interaction of Toll-like receptors with bacterial components induces expression of CDX2 and MUC2 in rat biliary epithelium in vivo and in culture. Lab Invest (2007) 0.97
Magnetic resonance imaging characteristics of bizarre parosteal osteochondromatous proliferation of the hand: a case report. J Hand Surg Am (2002) 0.97
Estrogenic activity of alkylphenols, bisphenol S, and their chlorinated derivatives using a GFP expression system. Environ Toxicol Pharmacol (2005) 0.96
Primary hyperoxaluria type 1 in Japan. Am J Nephrol (2005) 0.95
Successful outcomes using combination therapy of interleukin-2 and interferon-alpha for renal cell carcinoma patients with lung metastasis. Jpn J Clin Oncol (2010) 0.95
Phase I dose-escalation study of the novel antiandrogen BMS-641988 in patients with castration-resistant prostate cancer. Clin Cancer Res (2010) 0.95
Novel chromene derivatives as TNF-alpha inhibitors. Bioorg Med Chem Lett (2003) 0.94
Effects of a novel beta(3)-adrenoceptor agonist, AJ-9677, on relaxation of the detrusor muscle: an in vitro study. Int J Urol (2008) 0.93
Primary prostatic endodermal sinus tumor (yolk sac tumor) combined with a small focal seminoma. Am J Surg Pathol (2003) 0.93
Intrahepatic cholangiocarcinoma in cirrhosis presents granulocyte and granulocyte-macrophage colony-stimulating factor. Hum Pathol (2003) 0.93
Retinoic acid-inducible gene-I mediates RANTES/CCL5 expression in U373MG human astrocytoma cells stimulated with double-stranded RNA. Neurosci Res (2007) 0.93
Human muscarinic receptor binding characteristics of antimuscarinic agents to treat overactive bladder. J Urol (2006) 0.92
Discovery and structure-activity relationship of coumarin derivatives as TNF-alpha inhibitors. Bioorg Med Chem Lett (2004) 0.92
Reduction of transforming growth factor-beta type II receptor is caused by the enhanced ubiquitin-dependent degradation in human renal cell carcinoma. Int J Cancer (2010) 0.92
DPPH radical-scavenging compounds from dou-chi, a soybean fermented food. Biosci Biotechnol Biochem (2005) 0.92
Expression of IP-10/CXCL10 is upregulated by double-stranded RNA in BEAS-2B bronchial epithelial cells. Respiration (2006) 0.91
Quantitative trait locus analysis of serum insulin, triglyceride, total cholesterol and phospholipid levels in the (SM/J x A/J)F2 mice. Exp Anim (2003) 0.91
Prognostic factors of patients with metastatic renal cell carcinoma with removed metastases: a multicenter study of 556 patients. Urology (2013) 0.90
Hibernomas show intense accumulation of FDG positron emission tomography. J Comput Assist Tomogr (2006) 0.89
[Linguistic validation of Japanese version of International Prostate Symptom Score and BPH impact index]. Nihon Hinyokika Gakkai Zasshi (2002) 0.89
Expression of retinoic acid-inducible gene-I in vascular smooth muscle cells stimulated with interferon-gamma. Life Sci (2004) 0.89
Recurrent paralytic ileus associated with strongyloidiasis in a patient with systemic lupus erythematosus. Mod Rheumatol (2006) 0.89
Improvement of cardiac sympathetic innervation by renal transplantation. J Nucl Med (2004) 0.89
Cartilaginous features in matrix-producing carcinoma of the breast: four cases report with histochemical and immunohistochemical analysis of matrix molecules. Mod Pathol (2008) 0.89
Seasonal changes in symptom score and uroflowmetry in patients with lower urinary tract symptoms. Scand J Urol Nephrol (2007) 0.89
Near infrared spectroscopy study of the central nervous activity during artificial changes in bladder sensation in men. Int J Urol (2009) 0.88
Retrograde endoscopic management of ureteral stones more than 2 cm in size. Urology (2006) 0.88
Comparison of pharmacokinetics of mycophenolic acid and its glucuronide between patients with lupus nephritis and with kidney transplantation. Ther Drug Monit (2008) 0.88
Identification and characterization of a novel germ line p53 mutation in familial gastric cancer in the Japanese population. Carcinogenesis (2007) 0.88
S100A8 and S100A9 expression is a crucial factor for dedifferentiation in thyroid carcinoma. Anticancer Res (2009) 0.88
Efficacy of solifenacin on nocturia in Japanese patients with overactive bladder: impact on sleep evaluated by bladder diary. J Urol (2011) 0.88
Histological differences between invasive ductal carcinoma with a large central acellular zone and matrix-producing carcinoma of the breast. Pathol Int (2009) 0.87
Henoch-Schönlein pupura complicated by perforation of the gallbladder. Rheumatol Int (2008) 0.87
Prolonged treatment with three-weekly docetaxel plus daily prednisolone for metastatic castration-resistant prostate cancer: a multicenter, phase II, open-label, non-comparative, extension study in Japan. Int J Clin Oncol (2012) 0.87
Prognostic factors for metastatic urothelial carcinoma undergoing cisplatin-based salvage chemotherapy. Jpn J Clin Oncol (2013) 0.86
Follicular cholangitis and pancreatitis - clinicopathological features and differential diagnosis of an under-recognized entity. Histopathology (2012) 0.86
[Orotate phosphoribosyl transferase in bladder cancer]. Gan To Kagaku Ryoho (2004) 0.86
Intersubspecific subcongenic mouse strain analysis reveals closely linked QTLs with opposite effects on body weight. Mamm Genome (2011) 0.86
Significance of 5-fluorouracil-related enzyme activities in predicting sensitivity to 5-fluorouracil in bladder carcinoma. Anticancer Res (2009) 0.86
A wild derived quantitative trait locus on mouse chromosome 2 prevents obesity. BMC Genet (2010) 0.86
Impact of concentrative nucleoside transporter 1 gene polymorphism on oral bioavailability of mizoribine in stable kidney transplant recipients. Basic Clin Pharmacol Toxicol (2009) 0.86
Positive response to ice water test associated with high-grade bladder outlet obstruction in patients with benign prostatic hyperplasia. Urology (2003) 0.85
Contrast-enhanced magnetic resonance imaging of malignant granular cell tumor with pathological correlation: a case report. J Orthop Sci (2004) 0.85
Malignant granular cell tumor of the breast: case report and literature review. Breast Cancer (2012) 0.85
Babesia gibsoni: Serodiagnosis of infection in dogs by an enzyme-linked immunosorbent assay with recombinant BgTRAP. Exp Parasitol (2007) 0.85
Ubiquity and quantitative significance of detoxification catabolism of chlorophyll associated with protistan herbivory. Proc Natl Acad Sci U S A (2012) 0.85
Inappropriate elevation of serum thyrotropin levels in patients treated with axitinib. Thyroid (2013) 0.84